Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A review of the methods for human iPSC derivation.

Malik N, Rao MS.

Methods Mol Biol. 2013;997:23-33. doi: 10.1007/978-1-62703-348-0_3. Review.

2.

Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.

Lieu PT, Fontes A, Vemuri MC, Macarthur CC.

Methods Mol Biol. 2013;997:45-56. doi: 10.1007/978-1-62703-348-0_5.

PMID:
23546747
3.

Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.

Quintana-Bustamante O, Segovia JC.

Methods Mol Biol. 2016;1353:1-11. doi: 10.1007/7651_2014_170.

PMID:
25523810
4.

Small molecule inhibitors promote efficient generation of induced pluripotent stem cells from human skeletal myoblasts.

Trokovic R, Weltner J, Manninen T, Mikkola M, Lundin K, Hämäläinen R, Suomalainen A, Otonkoski T.

Stem Cells Dev. 2013 Jan 1;22(1):114-23. doi: 10.1089/scd.2012.0157. Epub 2012 Jul 30.

PMID:
22671711
5.

Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.

Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y.

Stem Cells Transl Med. 2012 Jun;1(6):451-61. doi: 10.5966/sctm.2011-0044. Epub 2012 May 30.

6.
7.

Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions.

Kishino Y, Seki T, Fujita J, Yuasa S, Tohyama S, Kunitomi A, Tabei R, Nakajima K, Okada M, Hirano A, Kanazawa H, Fukuda K.

PLoS One. 2014 May 13;9(5):e97397. doi: 10.1371/journal.pone.0097397. eCollection 2014.

8.

Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.

Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, Choi KD, Stewart R, Thomson JA, Slukvin II.

Blood. 2011 Apr 7;117(14):e109-19. doi: 10.1182/blood-2010-07-298331. Epub 2011 Feb 4.

9.

Generation and Characterization of Patient-Specific Induced Pluripotent Stem Cell for Disease Modeling.

Sivapatham R, Zeng X.

Methods Mol Biol. 2016;1353:25-44. doi: 10.1007/7651_2014_157.

PMID:
25520284
10.

Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Han JW, Yoon YS.

Antioxid Redox Signal. 2011 Oct 1;15(7):1799-820. doi: 10.1089/ars.2010.3814. Epub 2011 May 5. Review.

11.

Improved generation of patient-specific induced pluripotent stem cells using a chemically-defined and matrigel-based approach.

Groß B, Sgodda M, Rasche M, Schambach A, Göhring G, Schlegelberger B, Greber B, Linden T, Reinhardt D, Cantz T, Klusmann JH.

Curr Mol Med. 2013 Jun;13(5):765-76.

PMID:
23642058
12.

The choice of expression vector promoter is an important factor in the reprogramming of porcine fibroblasts into induced pluripotent cells.

Petkov S, Hyttel P, Niemann H.

Cell Reprogram. 2013 Feb;15(1):1-8. doi: 10.1089/cell.2012.0053.

PMID:
23379578
13.

RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications.

Bernal JA.

J Cardiovasc Transl Res. 2013 Dec;6(6):956-68. doi: 10.1007/s12265-013-9494-8. Epub 2013 Jul 13. Review.

14.

Generation of human-induced pluripotent stem cells (hiPSCs) using episomal vectors on defined Essential 8™ Medium conditions.

Fontes A, Macarthur CC, Lieu PT, Vemuri MC.

Methods Mol Biol. 2013;997:57-72. doi: 10.1007/978-1-62703-348-0_6.

PMID:
23546748
15.

A Comparative View on Easy to Deploy non-Integrating Methods for Patient-Specific iPSC Production.

Manzini S, Viiri LE, Marttila S, Aalto-Setälä K.

Stem Cell Rev. 2015 Dec;11(6):900-8. doi: 10.1007/s12015-015-9619-3.

16.

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.

Drozd AM, Walczak MP, Piaskowski S, Stoczynska-Fidelus E, Rieske P, Grzela DP.

Stem Cell Res Ther. 2015 Jun 19;6:122. doi: 10.1186/s13287-015-0112-3.

17.

Evolution of induced pluripotent stem cell technology.

Zhou H, Ding S.

Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Review.

PMID:
20442654
18.

Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs.

Mohseni R, Shoae-Hassani A, Verdi J.

Cell Biol Int. 2015 May;39(5):515-8. doi: 10.1002/cbin.10411. Epub 2015 Mar 15.

PMID:
25490878
19.

Progress in the reprogramming of somatic cells.

Ma T, Xie M, Laurent T, Ding S.

Circ Res. 2013 Feb 1;112(3):562-74. doi: 10.1161/CIRCRESAHA.111.249235. Review.

20.

Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, Pan J, Linton G, Chen L, Koontz S, Theobald NL, Malech HL.

Blood. 2013 Apr 4;121(14):e98-107. doi: 10.1182/blood-2012-03-420273. Epub 2013 Feb 5.

Supplemental Content

Support Center